Detalles de la búsqueda
1.
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients.
Int J Mol Sci
; 23(15)2022 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955661
2.
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.
Cancers (Basel)
; 15(6)2023 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980591
3.
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report.
Diagnostics (Basel)
; 12(5)2022 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626421
4.
Lack of TERT promoter mutations in melanomas with extensive regression.
J Am Acad Dermatol
; 74(3): 570-2, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892657
5.
MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.
Genes (Basel)
; 12(12)2021 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34946880
6.
MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
Melanoma Res
; 31(1): 18-26, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234848
7.
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.
Cancers (Basel)
; 11(8)2019 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31426418
8.
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.
Sci Rep
; 7(1): 495, 2017 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28356599
9.
Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.
Fam Cancer
; 15(2): 193-200, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26723934
10.
The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.
Fam Cancer
; 12(1): 119-23, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23117300
Resultados
1 -
10
de 10
1
Próxima >
>>